公司資料
Butterfly Network 股價、新聞與催化劑
- 股票代碼:
- BFLY
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
8.95 USD (+4.92%)
收盤價
最後更新: 2026年10月2日
1.2B USD
市值
股價為何變動
截至 2026年10月2日，BFLY 上漲 4.92%，收於 $8.95。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Point-of-Care Ultrasound Platform
Butterfly Network develops portable ultrasound systems intended to make medical imaging available wherever clinical decisions are made. Its platform combines handheld hardware, enterprise software, and artificial intelligence for use across hospitals, clinics, emergency settings, medical education, and other care environments.
Ultrasound-on-Chip Hardware
The Butterfly iQ family uses a semiconductor-based transducer architecture that replaces the multiple probes commonly required by conventional ultrasound systems. The current iQ3 device is designed as a single-probe, whole-body system that connects to a mobile device and supports a broad range of scanning applications.
Compass Software and AI
Butterfly Compass provides image acquisition, workflow management, documentation, credentialing, and enterprise connectivity. Compass AI adds guidance and measurement tools intended to help clinicians acquire diagnostic-quality images and standardize ultrasound use across different levels of experience.
Health-System and Education Customers
The company sells devices and software subscriptions to health systems, individual clinicians, medical schools, and international distributors. Enterprise deployments can place ultrasound across multiple departments while giving administrators centralized control over users, data, and clinical workflows.
Butterfly Embedded
Butterfly Embedded licenses the company's ultrasound technology to third parties developing their own medical devices and applications. This model extends the Ultrasound-on-Chip architecture beyond Butterfly-branded products through development collaborations, licensing, and potential component or software revenue.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。